However, this drug was associated with a slightly significant risk of serious atrial fibrillation and renal impairment in at-risk patients than placebo. 47 Some Important Adverse Effects of Anti-Resorptives In 2003, the first reports describing osteonecrosis of the jaw (ONJ) in patients receiving anti-resorptives including bisphosphonates and denosumab (see below) were published.
← all excerpts
2015 Guidelines for Osteoporosis in Saudi Arabia: Recommendations from the Saudi Osteoporosis Society.
1
—
—